Defunct Company
Total Trials
9
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,000
NCT02007473
A Prospective Non-interventional Study to Evaluate the Safety of Methylene Blue Plasma
Phase: N/A
Role: Collaborator
Start: Jul 31, 2013
Completion: May 31, 2015
NCT02317705
Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer
Phase: Phase 2
Start: Dec 31, 2014
Completion: Nov 30, 2015
NCT02348359
X-82 to Treat Age-related Macular Degeneration
Start: Mar 16, 2015
Completion: Jan 12, 2018
NCT02594254
Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects
Start: Nov 30, 2015
Completion: Sep 30, 2016
NCT02834312
E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)
Start: May 31, 2016
Completion: Jan 22, 2018
NCT03014115
Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants
Start: Nov 30, 2016
Completion: Aug 31, 2019
NCT03931993
A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL
Phase: Phase 1
Start: Jan 16, 2017
Completion: Apr 27, 2017
NCT03216226
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
Phase: Phase 3
Start: Jun 28, 2017
Completion: Feb 13, 2018
NCT03180307
OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
Start: Jan 26, 2018
Completion: Oct 16, 2020